OBJECTIVES: The objectives of this study were to determine the incidence density and the occurrence of horizontal spread of highly resistant gram-negative rods (HR-GNRs) in Dutch hospitals. The factors that influence these outcome measures were also investigated. METHODS: All patients with HR-GNRs, as determined by sample testing, who were hospitalized in 1 of 18 hospitals during a 6-month period (April through October 2007) were included in this study. For all available isolates, the species was identified, susceptibility was determined (including the presence of extended-spectrum β-lactamases [ESBLs]), and molecular typing was performed. On the basis of a combination of species identification, molecular typing, and epidemiological data, the occurrence of nosocomial transmission was determined. RESULTS: The mean incidence density of patients with HR-GNRs was 55 per 100,000 patient-days (cumulative incidence, 39 per 10,000 patients admitted). A facility being a university hospital was a statistically significant (P = .03) independent determinant of a higher incidence of patients with HR-GNRs. The majority of HR-GNR isolates were ESBL producers. The adjusted transmission index-the ratio between secondary and primary cases-in the participating hospitals ranged from 0.0 to 0.2. The overall adjusted transmission index of HR-GNRs was 0.07. No determinants for a higher transmission index were identified. DISCUSSION: The nosocomial transmission rate of HR-GNRs was relatively low in all hospitals where well-established transmission-based precautions were used. The incidence density of patients with HR-GNRs was higher in university hospitals, probably due to the patient population and the complexity of the care provided.
OBJECTIVES: The objectives of this study were to determine the incidence density and the occurrence of horizontal spread of highly resistant gram-negative rods (HR-GNRs) in Dutch hospitals. The factors that influence these outcome measures were also investigated. METHODS: All patients with HR-GNRs, as determined by sample testing, who were hospitalized in 1 of 18 hospitals during a 6-month period (April through October 2007) were included in this study. For all available isolates, the species was identified, susceptibility was determined (including the presence of extended-spectrum β-lactamases [ESBLs]), and molecular typing was performed. On the basis of a combination of species identification, molecular typing, and epidemiological data, the occurrence of nosocomial transmission was determined. RESULTS: The mean incidence density of patients with HR-GNRs was 55 per 100,000 patient-days (cumulative incidence, 39 per 10,000 patients admitted). A facility being a university hospital was a statistically significant (P = .03) independent determinant of a higher incidence of patients with HR-GNRs. The majority of HR-GNR isolates were ESBL producers. The adjusted transmission index-the ratio between secondary and primary cases-in the participating hospitals ranged from 0.0 to 0.2. The overall adjusted transmission index of HR-GNRs was 0.07. No determinants for a higher transmission index were identified. DISCUSSION: The nosocomial transmission rate of HR-GNRs was relatively low in all hospitals where well-established transmission-based precautions were used. The incidence density of patients with HR-GNRs was higher in university hospitals, probably due to the patient population and the complexity of the care provided.
Authors: Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny Journal: Dtsch Arztebl Int Date: 2012-01-20 Impact factor: 5.594
Authors: I T M A Overdevest; I Willemsen; S Elberts; C Verhulst; M Rijnsburger; P Savelkoul; J A J W Kluytmans Journal: J Clin Microbiol Date: 2011-08-24 Impact factor: 5.948
Authors: E Ascelijn Reuland; John P Hays; Denise M C de Jongh; Eman Abdelrehim; Ina Willemsen; Jan A J W Kluytmans; Paul H M Savelkoul; Christina M J E Vandenbroucke-Grauls; Nashwan al Naiemi Journal: PLoS One Date: 2014-03-18 Impact factor: 3.240
Authors: Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Bram Diederen; Patricia Houtman; Marina van Seventer; Ingeborg van Ess; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer Journal: Antimicrob Resist Infect Control Date: 2016-03-08 Impact factor: 4.887
Authors: Dennis Souverein; Stefan A Boers; Dick Veenendaal; Sjoerd M Euser; Jan Kluytmans; Jeroen W Den Boer Journal: PLoS One Date: 2014-06-27 Impact factor: 3.240
Authors: Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Corry Hattink; Patricia Houtman; Amerens Popma; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer Journal: Antimicrob Resist Infect Control Date: 2017-06-26 Impact factor: 4.887
Authors: Dennis Souverein; Sjoerd M Euser; Bjorn L Herpers; Jan Kluytmans; John W A Rossen; Jeroen W Den Boer Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240